Related Experiment Video
Updated: Dec 26, 2025
07:31
A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats
Published on: December 2, 2016
10.6K
Cardiac Remodeling in Chronic Kidney Disease
Nadine Kaesler1, Anne Babler1, Jürgen Floege1
1Clinic for Renal and Hypertensive Disorders, Rheumatological and Immunological Disease, University Hospital of the RWTH Aachen, 52074 Aachen, Germany.
Toxins
|March 11, 2020
Summary
Chronic kidney disease (CKD) severely impacts heart health through cardiorenal crosstalk, leading to cardiac remodeling and failure. This review explores mechanisms driving CKD-related heart disease and potential therapeutic targets.
Area of Science:
- Nephrology
- Cardiology
- Pathophysiology
Background:
- Chronic kidney disease (CKD) is linked to significant cardiac remodeling, impacting patient quality of life and survival.
- Existing treatments for CKD-related cardiac dysfunction are insufficient.
- The decline in kidney function disrupts metabolic pathways, affecting the heart via organ crosstalk.
Purpose of the Study:
- To review established and potential pathophysiological mechanisms of cardiorenal crosstalk in CKD.
- To identify how uremia-induced senescence and disease progression affect cardiac function.
- To explore potential therapeutic targets and relevant animal models for understanding and treating these conditions.
Main Methods:
- Literature review of established and potential pathophysiological cardiorenal crosstalk mechanisms.
- Analysis of factors contributing to cardiac remodeling in CKD patients.
- Examination of animal models for insights into disease progression and therapeutic strategies.
Main Results:
- CKD involves numerous factors like altered hemodynamics, metabolic disturbances, uremic toxins, and inflammation that stress the heart.
- These factors lead to left-ventricular hypertrophy, fibrosis, capillary rarefaction, and heart failure.
- Fibrosis in the heart contributes to electrical instability and sudden cardiac death.
Conclusions:
- Cardiorenal crosstalk is a critical driver of cardiac disease in CKD.
- Understanding these mechanisms is essential for developing novel therapeutics.
- Further research using animal models may elucidate new treatment strategies for uremia-induced cardiac pathology.
Related Concept Videos
01:18Chronic Kidney Disease IV: Nursing Management
242
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
242
01:25Chronic Kidney Disease I: Introduction
481
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
481
01:28Chronic Kidney Disease III: Interprofessional Care
276
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
276
01:24Chronic Kidney Disease II: Clinical Manifestations
480
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
480
01:17Pathophysiology of Heart Failure
2.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.6K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
823
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
823